Inspire Investing, LLC Myriad Genetics Inc Transaction History

Inspire Investing, LLC

$957 Million
Q3 2025

A detailed history of Inspire Investing, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Inspire Investing, LLC holds 79,686 shares of MYGN stock, worth $534,693. This represents 0.06% of its overall portfolio holdings.

Number of Shares

79,686

Previous 84,520 5.72%

Holding current value

$534,693

Previous $448,000 28.57%

% of portfolio

0.06%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$3.84 - $7.84 $18,562 - $37,898	-4,834 Reduced 5.72%	79,686 $576,000
Q2 2025 Jul 24, 2025	BUY	$3.84 - $8.84 $156,645 - $360,610	40,793 Added 93.29%	84,520 $448,000
Q1 2025 Jun 03, 2025	BUY	$8.87 - $14.98 $109,579 - $185,062	12,354 Added 39.38%	43,727 $387,000
Q4 2024 Jan 17, 2025	BUY	$13.17 - $27.03 $189,727 - $389,394	14,406 Added 84.91%	31,373 $430,000
Q3 2024 Oct 10, 2024	BUY	$23.97 - $28.6 $60,835 - $72,586	2,538 Added 17.59%	16,967 $464,000

Q2 2024 Aug 12, 2024	SELL	$17.98 - $25.47 $40,023 - $56,696	-2,226 Reduced 13.37%	14,429 $352,000
Q1 2024 May 07, 2024	SELL	$17.59 - $23.59 $62,602 - $83,956	-3,559 Reduced 17.61%	16,655 $355,000
Q4 2023 Feb 12, 2024	BUY	$13.91 - $21.32 $16,858 - $25,839	1,212 Added 6.38%	20,214 $386,000
Q3 2023 Oct 26, 2023	BUY	$15.99 - $23.22 $88,024 - $127,826	5,505 Added 40.79%	19,002 $304,000
Q2 2023 Jul 31, 2023	BUY	$17.56 - $23.76 $30,045 - $40,653	1,711 Added 14.52%	13,497 $312,000
Q1 2023 Apr 24, 2023	SELL	$15.26 - $23.75 $76,177 - $118,560	-4,992 Reduced 29.75%	11,786 $273,000
Q4 2022 Jan 26, 2023	BUY	$14.51 - $20.99 $89,221 - $129,067	6,149 Added 57.85%	16,778 $0
Q3 2022 Nov 07, 2022	SELL	$18.21 - $27.88 $18,027 - $27,601	-990 Reduced 8.52%	10,629 $203,000
Q2 2022 Aug 10, 2022	BUY	$16.45 - $25.88 $36,864 - $57,997	2,241 Added 23.9%	11,619 $211,000
Q1 2022 Apr 21, 2022	BUY	$22.67 - $28.01 $11,403 - $14,089	503 Added 5.67%	9,378 $236,000
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $214,153 - $289,591	8,875 New	8,875 $245,000
Q4 2021 Feb 03, 2022	SELL	$24.13 - $32.63 $168,813 - $228,279	-6,996 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$29.97 - $36.66 $35,604 - $43,552	-1,188 Reduced 14.52%	6,996 $226,000
Q2 2021 Aug 10, 2021	BUY	$25.39 - $32.61 $6,296 - $8,087	248 Added 3.13%	8,184 $250,000
Q1 2021 Apr 30, 2021	SELL	$19.92 - $31.6 $81,512 - $129,307	-4,092 Reduced 34.02%	7,936 $242,000
Q4 2020 Feb 12, 2021	SELL	$12.16 - $19.77 $7,393 - $12,020	-608 Reduced 4.81%	12,028 $238,000
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $142,155 - $186,381	12,636 New	12,636 $165,000
Q1 2018 Apr 13, 2018	SELL	$28.83 - $41.01 $46,618 - $66,313	-1,617 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$28.45 - $37.14 $46,003 - $60,055	1,617	1,617 $56,000

Others Institutions Holding MYGN

# of Institutions

239

Shares Held

92.1M

Call Options Held

86.1K

Put Options Held

18.9K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $541M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Account

Inspire Investing, LLC Myriad Genetics Inc Transaction History